According to a new study published by Polaris Market Research the global勃起功能障碍药物市场is anticipated to reach USD 2.63 billion by 2025. Impotence, also known as erectile dysfunction is the condition of sexual dysfunction where, during the sexual intercourse, men cannot maintain the erection. According to World Health Organization statement, for the emotional, physical and wellbeing of the individual, and to the economic and social development of countries and communities, sexual health is a fundamental thing. Erectile dysfunction affects the quality of life for both partners and patients and is connected with relationship difficulties.
勃起功能障碍通常是与年龄相关的病症，但也可以被心理因素引发。心血管疾病如高血压，堵塞动脉等，糖尿病，荷尔蒙不足，慢性肾脏疾病，多发性硬化，阴茎损伤，膀胱和骨盆，以及神经问题是可引起勃起功能障碍的常见因素。此外，久坐的生活方式，吸烟，过量的酒精摄入，肥胖和药物消费，如抗高血压药物，抗抑郁药，休闲药物和精神药物是一些其他因素，这些因素显着促进了勃起功能障碍。运动，药物治疗，均衡和维持生活方式，阴茎植入物，勃起装置和注射到阴茎中是可用于治疗勃起功能障碍的当前处理。目前，口服PDE5（磷酸二酯酶类型5抑制剂）是由勃起功能障碍的医生规定的第一线药物治疗。
全球口腔药物的可用性，以及对勃起功能障碍和性疾病的认识不起作用导致全球治疗的显着采用。此外，预计对二级护理和初级保健咨询的推荐数量将推动勃起功能障碍药物市场的增长。老年人人口增加和高慢性疾病率，如肾衰竭，糖尿病，高血压，激素不平衡和神经系统疾病正在增加全球勃起功能障碍药物的需求。
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:
//m.ptlymt.com/industry-analysis/erectile-dysfunction-drugs-market
The global erectile dysfunction drugs market is segmented on the basis of drug type, dosage form, end user, and geographically. On the basis of drug type, the global erectile dysfunction market is further segmented into Testosterone, Phosphodiestarse – 5 Inhibitors (PDE5I), Alprostadil, and others. Testosterone is hormone. The lack of testosterone hormone cause impotence or erectile dysfunction, and in such conditions, testosterone hormones are prescribed to the patient to balance the hormone in the body. The Phosphodiestarse – 5 Inhibitors is the drug used to control or block the degenerative action of c-GMP specific phosphodiesterase type 5 (PDE5) on cyclic GMP. The Sildenafil, Vardenafil, Tadalafil, Avanafil, Udenafil are the few examples of Phosphodiestarse – 5 Inhibitors. The Phosphodiestarse – 5 Inhibitors drugs are most commonly prescribed drugs to treat erectile dysfunction and hence accounted major share in global erectile dysfunction drugs market.
The high effectiveness and efficacy of Phosphodiestarse – 5 Inhibitors are the major factors contributing towards the large share in the global erectile dysfunction market. The introduction of long effective pills such as Levitra (vardenafil) and Cialis (tadalafil) are effective for 36 hours and hence they are also know as weekend pill. Moreover, the increasing research and development and various drugs for erectile dysfunction are in various stages of pipeline. The introduction of such blockbuster drugs in the market over the forecast period is expected to propel the growth of erectile dysfunction market globally.
通过剂量形式，全球勃起功能障碍药物市场进一步分段为局部，口服，注射和其他。口头分部占全球勃起功能障碍药物市场的主要份额。口腔药物更方便处理剂量，因此它是高优选的剂型。预计注射段预计将在预测期内生长。